Yayınlar & Eserler

Yayın Ağı
Makaleler 3
Tümü (3)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (3)
Scopus (3)

1. Suppression of glioblastoma progression by novel Phthalocyanine derivatives: In vitro characterization and molecular docking analysis

Ayvaz Ş., Batan N., İnan C., Güler H. İ., Değirmencioğlu İ.
JOURNAL OF INORGANIC BIOCHEMISTRY , cilt.283, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. BH3 mimetic and dual PI3K/mTOR inhibitor attenuates gemcitabine resistance in triple-negative breast cancer

Selimoglu G., Ayvaz Ş., Bolat Z. B.
MEDICAL ONCOLOGY , cilt.43, sa.1, 2025 (SCI-Expanded, Scopus)

3. All-trans retinoic acid enhances anti-proliferative effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in triple negative breast cancer

Ayvaz Ş., Bolat Z. B.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , cilt.398, ss.10855-10865, 2025 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. Methylation Fingerprints of Colorectal Cancer: From Normal Tissue to Liver and Brain Metastasis

Ayvaz Ş., Turan B., Batan N., İnan C.
Annual Congress of the European Association for Cancer Research (EACR 2026), Budapest, Macaristan, 8 - 11 Haziran 2026, ss.1, (Özet Bildiri)

2. Evaluation of Coumarin and Triazole Derived Heterocyclic Compounds in Glioblastoma Cells Using In Vitro and In Silico Approaches

Ayvaz Ş., Çakmak I., İnan C., Batan N., Gümrükçüoğlu N.
MOKAD 2026 (XI. Multidisipliner Kanser Araştırma Kongresi), İstanbul, Türkiye, 2 - 05 Temmuz 2026, ss.1, (Özet Bildiri)

3. DNA Methylation Profiling of Colorectal Cancer Liver Metastasis: Identification of Core Biomarkers and Functional Pathways

Ayvaz Ş., İnan C., Batan N.
European Human Genetics Conference (ESHG 2026), Gothenburg, İsveç, 13 - 16 Haziran 2026, ss.1, (Özet Bildiri)

4. Evaluation of Antimicrobial and Cytotoxic Activities of Methanolic and Aqueous Extracts of Alchemilla mollis (Buser) Rothm.

Ayvaz S. B., Ayvaz Ş., Batan N.
III. INTERNATIONAL APITHERAPY AND NATURE CONGRESS IANCO25, Baku, Azerbaycan, 21 - 23 Kasım 2025, ss.32, (Özet Bildiri)

5. Targeted Delivery of NVPBEZ235 conjugated to gold nanoparticles for Overcoming Gemcitabine Resistance in Triple-Negative Breast Cancer

Ayvaz Ş., Akgün E., Yeşilay G., Bolat Z. B.
The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025), Lisbon, Portekiz, 16 Haziran - 19 Temmuz 2025, cilt.19, ss.352-353, (Özet Bildiri) Creative Commons License

6. Overcoming Gemcitabine Resistance in MDA-MB-231 Cells: A Synergistic Approach Using ABT-737 and NVPBEZ235 Dual Inhibition of PI3K/mTOR

Selimoğlu G., Ayvaz Ş., Bolat Z. B.
The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025), Lisbon, Portekiz, 16 Haziran - 19 Temmuz 2025, cilt.19, ss.352, (Özet Bildiri) Creative Commons License

7. Synergistic effect of Dacomitinib and Olaparib combination on Gemcitabine-Resistant Triple Negative Breast Cancer MDA-MB-231 cell line

Bolat Z. B., Ayvaz Ş.
Moleküler Biyoloji Derneği 9. Uluslararası Kongresi, İzmir, Türkiye, 12 - 14 Eylül 2024, ss.1, (Özet Bildiri)

8. Anti-proliferative Effect of Dacomitinib and Retinoic Acid on Triple Negative Breast Cancer

Ayvaz Ş., Bolat Z. B.
3rd International Multidisciplinary Cancer Research Congress, İstanbul, Türkiye, 7 - 09 Eylül 2023, ss.102, (Özet Bildiri)

9. İndolamin-2,3-dioksijenaz-1 inhibitörleri uygulanan triple negatif meme kanseri hücrelerinde immün kaçışta miR-34a ve miR-155'in rolünün araştırılması

Hamarat K. F., Ayvaz Ş., Güney G.
4th International Conference on Applied Engineering and Natural Sciences, Konya, Türkiye, 10 - 13 Kasım 2022, ss.1112-1116, (Tam Metin Bildiri) Creative Commons License
Metrikler

Yayın

13

Yayın (WoS)

3

Yayın (Scopus)

3

Proje

1

Açık Erişim

4